Aggressive lipid-lowering therapy after percutaneous coronary intervention-for whom and how?
Percutaneous coronary intervention (PCI) has been established as a definitive method to treat obstructive coronary artery disease. The procedure on its own, however, is insufficient to ensure optimal longterm patient outcomes as it is also necessary to achieve good control of relevant risk factors....
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | 論文 |
| 出版事項: |
Europa Group
2022
|
| 主題: | |
| オンライン･アクセス: | http://eprints.um.edu.my/43936/ |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
このレコードへの初めてのコメントを付けませんか!